Sun Pharma Advanced Research Company has informed that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 to consider and approve the Unaudited financial Results for the quarter ended June 30, 2022 and to evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
The above information is a part of company’s filings submitted to BSE.